Ten-year results of transscleral resection of large uveal melanomas: local tumour control and metastatic rate

被引:40
作者
Bechrakis, Nikolaos E. [1 ]
Petousis, Vasileios [2 ]
Willerding, Gregor [2 ]
Krause, Lothar [3 ]
Wachtlin, Joachim [4 ]
Stroux, Andrea [5 ]
Foerster, Michael H. [2 ]
机构
[1] Innsbruck Med Univ, Dept Ophthalmol, A-6020 Innsbruck, Austria
[2] Charite, Dept Ophthalmol, D-13353 Berlin, Germany
[3] Stadt Klinikum Dessau, Dept Ophthalmol, Dessau, Germany
[4] Sankt Getrauden, Dept Ophthalmol, Berlin, Germany
[5] Charite, Inst Biostat, D-13353 Berlin, Germany
关键词
PROTON-BEAM RADIOTHERAPY; IODINE BRACHYTHERAPY; OCULAR COMPLICATIONS; PLAQUE RADIOTHERAPY; EXPERIENCE; EXCISION; EYE;
D O I
10.1136/bjo.2009.162487
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims To describe the long-term tumour control and metastatic rate after transscleral resection (TSR) of large uveal melanomas in a single-centre study. Methods The sample included 210 patients with large uveal melanomas. Univariate analysis of local tumour control and metastatic risk by Kaplan-Meier survival curves and log-rank testing. Cox proportional HR analysis with forward and backward selection was used to identify independent prognostic factors in patients submitted to TSR of a large uveal melanoma. Results A residual tumour was diagnosed in 6% of the patients. The 5- and 10-year local tumour recurrence rates were 24% and 32%, respectively. Older age, a large basal tumour diameter, the lack of adjuvant ruthenium brachytherapy and retinal detachment led to a 2.6, 2.4, 4.4 and 7.8 times higher risk of melanoma recurrence, respectively. The 5- and 10-year metastatic rates were 28% and 44%, respectively, and were statistical significantly affected by extraocular spread, tumour thickness and local tumour recurrence. Conclusions TSR is an alternative to enucleation for the treatment of large uveal melanomas. Results should improve with better patient selection and more effective methods of adjuvant radiotherapy.
引用
收藏
页码:460 / 466
页数:7
相关论文
共 22 条
[1]   Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas [J].
Bechrakis, NE ;
Bornfeld, N ;
Zöller, I ;
Foerster, MH .
OPHTHALMOLOGY, 2002, 109 (10) :1855-1861
[2]  
Bechrakis Nikolaos E., 2006, International Ophthalmology Clinics, V46, P95, DOI 10.1097/01.iio.0000195856.31324.00
[3]  
Collaborative Ocular Melanoma Grp, 2006, ARCH OPHTHALMOL-CHIC, V124, P1684
[4]   Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy [J].
Conway, R. Max. ;
Poothullil, Antony M. ;
Daftari, Inder K. ;
Weinberg, Vivian ;
Chung, Juliet E. ;
O'Brien, Joan M. .
ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (06) :838-843
[5]  
Damato B, 1997, FRONT RADIAT THER ON, V30, P123
[6]   Risk factors for metastatic uveal melanoma after trans-scleral local resection [J].
Damato, BE ;
Paul, J ;
Foulds, WS .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1996, 80 (02) :109-116
[7]  
Damato Bertil, 2006, International Ophthalmology Clinics, V46, P81, DOI 10.1097/01.iio.0000195862.71558.c8
[8]   Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma [J].
Egger, E ;
Schalenbourg, A ;
Zografos, L ;
Bercher, L ;
Boehringer, T ;
Chamot, L ;
Goitein, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01) :138-147
[9]  
FOULDS WS, 1977, T OPHTHAL SOC UK, V97, P412
[10]  
FOULDS WS, 1973, T OPHTHAL SOC UK, V93, P343